Back to search
Ventricular Tachycardia Ablation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ventricular Tachycardia Ablation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ventricular Tachycardia Ablation trials you may qualify forThe purpose of the first phase of this feasibility study is to gather safety and performance data on MAGiC to support European marketing approval. The purpose…
RADIATE-VT is a pivotal, multicenter, randomized trial comparing safety and efficacy between cardiac radioablation (CRA) using the Varian CRA System and repeat…
Ventricular tachycardia (VT) is a life-threatening heart rhythm disorder. Special pacemakers called implantable cardiac defibrillators (ICDs) help treat VT epis…
This prospective, multicenter, open-label, randomized-controlled trial compares two treatment strategies in high-risk ischemic cardiomyopathy (ICM) patients ref…
This study is investigating whether using ultrasound directly inside the heart during ablation of heart rhythm disorders in the ventricles can reduce radiation…
Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol…
Background: Ventricular arrhythmia is an abnormal pulse rhythm that starts in the lower part of the heart (ventricles). Treatment includes ablation; ablation u…
Ventricular tachycardia (VT) is a life-threatening heart rhythm disorder and one of the commonest causes of heart-related sudden death. It often affects people…